Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Comet share sale and debt repayment July 28, 2025 Agreement to Develop New Expandable Graphite Facility July 28, 2025 Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025